Amer N. Kalaaji, M.D.

  1. Dermatologist
  1. Tekin B, Johnson EF, Wieland CN, Gibson LE, Camilleri MJ, Kalaaji AN, Comfere NI, Peters MS, Lehman JS. Histopathology of autoimmune bullous dermatoses: what's new? Hum Pathol. 2022 Oct; 128:69-89 Epub 2022 June 25
    View PubMed
  2. Lehman JS, Johnson EF, Camilleri MJ, Gibson LE, Comfere NI, Kalaaji AN, Peters MS, Cervenka DJ, Doppler JM, Lange CR, Miller CJ, Wieland CN. Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders. J Cutan Pathol. 2022 Apr; 49(4):358-362. Epub 2021 Dec 20.
    View PubMed
  3. Gonzalez Santiago TM, Wetter DA, Kalaaji AN, Limper AH, Lehman JS. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis. Int J Dermatol. 2016 Aug; 55 (8):823-30 Epub 2016 Mar 24
    View PubMed
  4. Gonzalez Santiago TM, Lehman JS, Buonaccorsi JN, Kalaaji AN, Wieland CN. Frequency of cutis laxa-like clinical features and elastolysis in scleromyxedema: a retrospective clinicopathologic study of 19 patients with scleromyxedema. J Cutan Pathol. 2016 Mar; 43: (3)246-51.
    View PubMed
  5. Shon W, Wada DA, Kalaaji AN. Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies. Cutis. 2016 Mar; 97: (3)219-22.
    View PubMed
  6. Kalaaji AN, Wallo W. A randomized controlled clinical study to evaluate the effectiveness of an active moisturizing lotion with colloidal oatmeal skin protectant versus its vehicle for the relief of xerosis. Journal Of Drugs In Dermatology. 2014 Oct; 13(10):1265-8.
    View PubMed
  7. Lehman JS, Wetter DA, Davis MD, el-Azhary RA, Gibson LE, Kalaaji AN. Anticipating and preventing infection in patients treated with immunosuppressive medications for dermatologic indications: a dermatologist's checklist. J Am Acad Dermatol. 2014 Oct; 71(4):e125-6.
    View PubMed
  8. Barbosa NS, Kalaaji AN. CAM use in dermatology. Is there a potential role for honey, green tea, and vitamin C? Complement Ther Clin Pract. 2014 Feb; 20 (1):11-5 Epub 2013 Nov 20
    View PubMed
  9. Barrick BJ, Bruce AJ, Kalaaji AN, Bauer BA. Clinical improvement of recalcitrant cutaneous sarcoidosis with regular nutritional supplementation with extract of the prickly pear cactus. Explore (NY). 2013 Nov-Dec; 9(6):377-8.
    View PubMed
  10. Shon, Kalajji AN, Wade. Radiation-Induced Pemphigus/Pemphigoid Disease in 3 Patients With Distinct Underlying Malignancies (2013 publication pending). Cutis. 2013.
  11. Kalaaji AN, Wahner-Roedler DL, Sood A, Chon TY, Loehrer LL, Cha SS, Bauer BA. Use of complementary and alternative medicine by patients seen at the dermatology department of a tertiary care center. Complement Ther Clin Pract. 2012 Feb; 18 (1):49-53 Epub 2011 June 24
    View PubMed
  12. Lehman JS, Kalaaji AN, Rogers RS 3rd, Stone RA. Pemphigoid nodularis: a case report. Cutis. 2011 Nov; 88(5):224-6.
    View PubMed
  13. Lehman JS, Murrell DF, Camilleri MJ, Kalaaji AN. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders. Dermatol Clin. 2011 Oct; 29(4):591-8.
    View PubMed
  14. Lehman JS, Kalaaji AN, Rogers RS, Store RN. Case Report: Pemphigoid Nodularis. Cutis. 2011 (in press).
  15. Lehman JS, Kalaaji AN. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions. J Am Acad Dermatol. 2010 Nov; 63(5):815-23.
    View PubMed
  16. Gerhart JL, Kalaaji AN. Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications. J Am Acad Dermatol. 2010 Jun; 62(6):957-61. Epub 2009 Oct 13.
    View PubMed
  17. Knudson RM, Kalaaji AN, Bruce AJ. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther. 2010 May-Jun; 23(3):268-80.
    View PubMed
  18. Kalaaji AN, Lu J, Markovic SN, Celis E, Pittelkow MR. Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model. Cytokine. 2010 Mar; 49(3):287-93. Epub 2010 Jan 08.
    View PubMed
  19. Khan YK, Kalaaji AN, Clarke BL. Glucocorticoid-induced osteoporosis in dermatologic practice: a review. J Drugs Dermatol. 2008 Nov; 7(11):1053-9.
    View PubMed
  20. Passe AM, Davis MD, Kalaaji AN. Pruritic rash on the buttocks after a beach vacation: a case report. Cutis. 2008 Aug; 82(2):133-4.
    View PubMed
  21. Eid AJ, Davis MD, Bingham LG, Kalaaji AN, Enzler M, Razonable RR, Berbari EF. A young man with pyomyositis and bullous disease. Clin Infect Dis. 2007 Sep 15; 45(6):741, 799-800.
    View PubMed
  22. Kalaaji AN. Cytokine therapy in advanced melanoma. J Drugs Dermatol. 2007 Apr; 6(4):374-8.
    View PubMed
  23. Hecksel KA, Kalaaji AN. Distinguishing pemphigus and pemphigoid for the non-dermatologist. Clinical Geriatrics. 2007; 15(11):41-5.
  24. Kureshi F, Kalaaji AN, Halvorson L, Pittelkow MR, Davis MD. Cutaneous complications of intravesical treatments for bladder cancer: granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy. J Am Acad Dermatol. 2006 Aug; 55(2):328-31.
    View PubMed
  25. Holman DM, Kalaaji AN. Cytokines in dermatology. J Drugs Dermatol. 2006 Jun; 5(6):520-4.
    View PubMed
  26. Alexander JL, Kalaaji AN, Shehan JM, Yokel BK, Pittelkow MR. Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. J Drugs Dermatol. 2006 Jun; 5(6):534-7.
    View PubMed
  27. Shehan JM, Kalaaji AN. Pancreatic panniculitis due to pancreatic carcinoma. Mayo Clin Proc. 2005 Jun; 80: (6)822.
    View PubMed
  28. Shehan JM, Kalaaji AN, Markovic SN, Ahmed I. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. J Am Acad Dermatol. 2004 Jul; 51 (1):103-10
    View PubMed
  29. Kuhl J, Davis MD, Kalaaji AN, Kamath PS, Hand JL, Peine CJ. Skin signs as the presenting manifestation of severe nutritional deficiency: report of 2 cases. Arch Dermatol. 2004 May; 140(5):521-4.
    View PubMed
  30. Shehan JM, Clowers-Webb HE, Kalaaji AN. Recurrent palmoplantar hidradenitis with exclusive palmar involvement and an association with trauma and exposure to aluminum dust. Pediatr Dermatol. 2004 Jan-Feb; 21 (1):30-2
    View PubMed
  31. Kelkar PS, Butterfield JH, Kalaaji AN. Urticarial vasculitis with asymptomatic chronic hepatitis C infection: Response to doxepin, interferon-alfa, and ribavirin. J Clin Gastroenterol. 2002 Sep; 35(3):281-2.
    View PubMed
  32. Cole R, Gibson L, Kalaaji AN, et al. Russel bodies and rosacea? A case of marginal zone B-cell lymphoma (MALT) clinically masquerading as acne rosacea. J Cutan Pathol. 2000; 27:553.
  33. Kalaaji AN, Douglass MC, Chaffins M, Lowe L. Calciphylaxis: a cause of necrotic ulcers in renal failure. Journal of Cutaneous Medicine & Surgery. 1998 Apr; 2(4):242-4.
    View PubMed
  34. Hay JB, Abernethy NJ, Kalaaji AN, Teare GF, Borron P. The relevance of lymphoid cell migration to immunodeficiency syndromes. Lymphology. 1990 Jun; 23(2):64-72.
    View PubMed
  35. Kalaaji AN, McCullough K, Hay JB. The enhancement of lymphocyte localization in skin sites of sheep by tumor necrosis factor alpha. Immunol Lett. 1989 Dec; 23(2):143-7.
    View PubMed
  36. Kalaaji AN, Abernethy NJ, McCullough K, Hay JB. Recombinant bovine interferon-alpha I 1 inhibits the migration of lymphocytes from lymph nodes but not into lymph nodes. Reg Immunol. 1988 Jul-Aug; 1(1):56-61.
    View PubMed